Furthermore, CD44, a surface adhesion molecule and marker of cancer stem cells, has also been found to mediate tumor cell aggregation in a patient-derived breast cancer model through homophilic interaction and downstream activation of FAK signaling [44]. This evidence concerns the gene CD44 and cancer.